171 related articles for article (PubMed ID: 36171325)
21. Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
Ikesue H; Yamaoka K; Matsumoto A; Hirabatake M; Muroi N; Yamasaki T; Kawakita M; Hashida T
Cancer Chemother Pharmacol; 2022 Jun; 89(6):833-838. PubMed ID: 35254504
[TBL] [Abstract][Full Text] [Related]
22. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
23. Should ACE inhibitors and ARBs be used in combination in children?
Stotter BR; Ferguson MA
Pediatr Nephrol; 2019 Sep; 34(9):1521-1532. PubMed ID: 30112656
[TBL] [Abstract][Full Text] [Related]
24. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
25. Can Renin-Angiotensin System Inhibitors Protect Against Acute Kidney Injury in Patients With COVID-19?
Kow CS; Ramachandram DS; Hasan SS
Crit Care Med; 2022 Nov; 50(11):e796-e797. PubMed ID: 36227048
[No Abstract] [Full Text] [Related]
26. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation.
Uchida M; Ushio S; Niimura T; Takechi K; Kawazoe H; Hidaka N; Tanaka A; Araki H; Zamami Y; Ishizawa K; Kitamura Y; Sendou T; Kawasaki H; Namba H; Shibata K; Tanaka M; Takatori S
Biol Pharm Bull; 2022 Feb; 45(2):226-234. PubMed ID: 34803077
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.
Bhaskaran K; Douglas I; Evans S; van Staa T; Smeeth L
BMJ; 2012 Apr; 344():e2697. PubMed ID: 22531797
[TBL] [Abstract][Full Text] [Related]
28. The Potential Therapeutic Value of Renin-Angiotensin System Inhibitors in the Treatment of Colorectal Cancer.
Tabatabai E; Khazaei M; Parizadeh MR; Nouri M; Hassanian SM; Ferns GA; Rahmati M; Avan A
Curr Pharm Des; 2022; 28(1):71-76. PubMed ID: 34635038
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Yoshida T; Kinoshita H; Fukui K; Matsuzaki T; Yoshida K; Mishima T; Yanishi M; Komai Y; Sugi M; Inoue T; Murota T; Matsuda T
Ann Surg Oncol; 2017 Mar; 24(3):823-831. PubMed ID: 27730369
[TBL] [Abstract][Full Text] [Related]
30. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
32. Impact of Renin-angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients.
Tozuka T; Yanagitani N; Yoshida H; Manabe R; Ogusu S; Tsugitomi R; Sakamoto H; Amino Y; Ariyasu R; Uchibori K; Kitazono S; Seike M; Gemma A; Nishio M
Anticancer Res; 2021 Apr; 41(4):2093-2100. PubMed ID: 33813419
[TBL] [Abstract][Full Text] [Related]
33. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
Tsampasian V; Corballis N; Vassiliou VS
Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
[TBL] [Abstract][Full Text] [Related]
34. Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Aparisi Á; Catalá P; Amat-Santos IJ; Marcos-Mangas M; López-Otero D; Veras C; López-Pais J; Cabezón-Villalba G; Cacho Antonio CE; Candela J; Antúnez-Muiños P; Gil JF; González Ferrero T; Rojas G; Pérez-Poza M; Uribarri A; Otero-García O; García-Granja PE; Jiménez Ramos V; Revilla A; Dueñas C; Gómez I; González-Juanatey JR; San Román JA
Med Clin (Barc); 2022 Apr; 158(7):315-323. PubMed ID: 34088524
[TBL] [Abstract][Full Text] [Related]
35. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
Chen C; Wang F; Chen P; Jiang J; Cui G; Zhou N; Moroni F; Moslehi JJ; Ammirati E; Wang DW
J Am Heart Assoc; 2020 Nov; 9(21):e017736. PubMed ID: 32807002
[TBL] [Abstract][Full Text] [Related]
36. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
37. Effect of Renin-Angiotensin-Aldosterone System Blockade on Long-Term Outcomes in Postacute Kidney Injury Patients With Hypertension.
Yang CY; Liu JS; Tseng WC; Tsai MT; Lin MH; Kao ZK; Lin YP; Hsu CC; Tarng DC
Crit Care Med; 2020 Dec; 48(12):e1185-e1193. PubMed ID: 32932351
[TBL] [Abstract][Full Text] [Related]
38. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
Weber MA
J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
Opelz G; Döhler B
Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
[TBL] [Abstract][Full Text] [Related]
40. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]